CClinicalTrials.gg
CompletedNCT05933759WeR-LIMUpdated Jul 11, 2024

Weight Reduction With the Low-Insulin-Method

An interventional study of Telemedical coaching and Low-Insulin-Method in Overweight and Obesity, sponsored by West German Center of Diabetes and Health. Completed at 1 site in Germany. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-07-11.

Sponsored by West German Center of Diabetes and Health · Not applicable, Interventional, and Supportive care

Phase
Not applicable
Study type
Interventional
Enrollment
65
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

Background: Overweight and obesity affect health, quality of life and ability to work. Therefore, the Low-Insulin-Method was developed to support overweight and obese people in weight loss.

Method: In a randomized controlled clinical trial, the effect of the lifestyle intervention program 'Low-Insulin-Method', delivered by the Low-Insulin-App including low-carb diet, self monitoring of weight, physical activity and telemedical coaching is examined compared to a control group without coaching. The learning contents are taught in 30 videos and 5 online meetings. The intervention group additionally gets 4 individual care calls. The state of health is examined at the beginning and after 12 weeks.

Objective: The aim is to develop a training and counseling program for overweight or obese individuals with diabetes risk or type 2 diabetes, which can be used both for primary and for tertiary prevention of overweight-related diseases.

02

Conditions studied

  • Overweight and Obesity
03

In context

Overweight

3,670 studies on the registry are indexed under Overweight; 849 are open to participants now.

This study's enrollment of 65 is below the median of 73 across 3,175 interventional studies indexed under Overweight.

Browse Overweight studies →

Lead sponsor

West German Center of Diabetes and Health is the lead sponsor of 18 studies on the registry; 1 is open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Body Mass Index 25 kg/m2

Exclusion criteria

Exclusion Criteria:

  • none
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Investigator, Outcomes assessor)
Enrollment
65 participants (actual)

Study arms

  • Experimental
    Intervention group

    Lifestyle intervention with education via the Low-Insulin-App, low-carb diet, self-monitoring of weight and steps, and telemedical coaching.

    Behavioral: Telemedical coaching · Behavioral: Low-Insulin-Method

  • Active comparator
    Control group

    Lifestyle intervention with education via the Low-Insulin-App, low-carb diet, self-monitoring of weight and steps.

    Behavioral: Low-Insulin-Method

Interventions

  • BehavioralTelemedical coaching

    Individual telemedical coaching delivered by a nutritional consultant

  • BehavioralLow-Insulin-Method

    Lifestyle intervention with education via the Low-Insulin-App, low-carb diet, self-monitoring of weight and steps

06

What researchers measure

Primary outcomes

  1. Weight change in kg

    Estimated treatment difference

    Time frame: 12 weeks

Secondary outcomes

  1. body mass index in kg/m2

    Estimated treatment difference

    Time frame: 12 weeks

  2. waist circumference in cm

    Estimated treatment difference

    Time frame: 12 weeks

  3. hip circumference in cm

    Estimated treatment difference

    Time frame: 12 weeks

  4. fat mass in kg

    Estimated treatment difference

    Time frame: 12 weeks

  5. lean body mass in kg

    Estimated treatment difference

    Time frame: 12 weeks

  6. muscle mass in kg

    Estimated treatment difference

    Time frame: 12 weeks

  7. energy expenditure in kcal

    Estimated treatment difference

    Time frame: 12 weeks

  8. blood pressure in mmHg

    Estimated treatment difference

    Time frame: 12 weeks

  9. quality of life (short form questionnaire) in units on a scale

    Estimated treatment difference minimum 0, maximum 100 higher scores mean a better outcome

    Time frame: 12 weeks

  10. depression (German version of the Center for Epidemiological Studies-Depression Scale) in units on a scale

    Estimated treatment difference minimum 0, maximum 100 higher scores mean a worse outcome

    Time frame: 12 weeks

  11. physical activity in min/day

    Estimated treatment difference

    Time frame: 12 weeks

  12. physical activity in steps/day

    Estimated treatment difference

    Time frame: 12 weeks

  13. eating behaviour (German version of the Three-factor Eating Questionnaire) in units on a scale

    Estimated treatment difference minimum 0, maximum 100 higher scores mean a better outcome

    Time frame: 12 weeks

  14. total cholesterol in mg/dl

    Estimated treatment difference

    Time frame: 12 weeks

  15. HDL cholesterol in mg/dl

    Estimated treatment difference

    Time frame: 12 weeks

  16. LDL cholesterol in mg/dl

    Estimated treatment difference

    Time frame: 12 weeks

  17. triglycerides in mg/dl

    Estimated treatment difference

    Time frame: 12 weeks

  18. fasting blood glucose in mg/dl

    Estimated treatment difference

    Time frame: 12 weeks

  19. insulin in µU/ml

    Estimated treatment difference

    Time frame: 12 weeks

  20. HbA1c in %

    Estimated treatment difference

    Time frame: 12 weeks

  21. food frequency (German version of the food frequency questionnaire) in units on a scale

    Estimated treatment difference minimum 0, maximum 100 higher scores mean a better outcome

    Time frame: 12 weeks

Other outcomes

  1. gut microbiome composition in percent

    difference between groups

    Time frame: 12 weeks

07

Study locations

1 site
  • West German Centre of Diabetes and Health
    Düsseldorf, 40591, Germany
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 11, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05933759
Lead sponsor
West German Center of Diabetes and Health
Collaborators
University of Bonn
Responsible party
Sponsor
First posted
Jul 6, 2023
Start date
Jul 15, 2023
Primary completion
Dec 31, 2023
Completion
Jun 30, 2024
Last update
Jul 11, 2024

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion